A Multi-center, Prospective, Single-arm, Open Label Phase II Study of Chidamide Combined With Chemotherapy in the Treatment of Peripheral T Cell Lymphoma
Phase of Trial: Phase II
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Tucidinostat (Primary)
- Indications Peripheral T-cell lymphoma
- Focus Therapeutic Use
- 10 Nov 2017 Planned End Date changed from 1 Nov 2018 to 1 Nov 2019.
- 10 Nov 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2018.
- 02 May 2016 New trial record